EMEA-002352-PIP01-18
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0245/2018
|
| PIP number |
EMEA-002352-PIP01-18
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Sanofi- Aventis Research & Development
Tel. +33 169745695 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|